FidoCure Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 23
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $10M
Latest Deal Amount
  • Investors
  • 13

FidoCure General Information

Description

Provider of personalized medicine intended for dogs offering advanced cancer care beyond chemo and radiation. The company collects a tissue sample for DNA sequencing and creates a personalized DNA report that helps identify genetic mutations that may affect treatment and then suggests targeted therapy to precisely attack the cancer cells, enabling pet owners and veterinarians to eradicate canine cancer, improve the quality of life for canine patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Primary Office
  • 530 Lytton Avenue
  • 2nd Floor
  • Palo Alto, CA 94301
  • United States
+1 (215) 000-0000

FidoCure Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

FidoCure Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC (Series A) 29-Oct-2020 $10M 000.00 000.00 Completed Generating Revenue
8. Seed Round 23-Jan-2019 000 00.000 000.00 Completed Generating Revenue
7. Secondary Transaction - Private 17-May-2018 00.000 Completed Generating Revenue
6. Debt - General 00.000 Completed Generating Revenue
5. Accelerator/Incubator 20-Mar-2018 00000 00.000 00.000 Completed Generating Revenue
4. Accelerator/Incubator 16-Jun-2017 0000 00.000 Completed Generating Revenue
3. Seed Round 01-Mar-2017 00.000 00.000 Completed Generating Revenue
2. Accelerator/Incubator 09-Apr-2016 Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2016 Completed Generating Revenue
To view FidoCure’s complete valuation and funding history, request access »

FidoCure Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Seed 000,000 00.000000 00.00 00.00 00.00 00 00.00 00.00
To view FidoCure’s complete cap table history, request access »

FidoCure Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of personalized medicine intended for dogs offering advanced cancer care beyond chemo and radiation. The compan
Other Pharmaceuticals and Biotechnology
Palo Alto, CA
23 As of 2020
000.00
00.00 0000-00-00
00000000000 000.00

00000000

lore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliqui
0000000000 00000000 (0000000000)
Harvard, MA

00000

quip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum
00000 00000000 (000 000-000000000)
Martinsried, Germany
0 As of 0000
00.000
0000000000 0 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

FidoCure Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Innogenics Corporation Harvard, MA
00000 Venture Capital-Backed Martinsried, Germany 0 00.000 0000000000 0 00.000
You’re viewing 2 of 2 competitors. Get the full list »

FidoCure Executive Team (11)

Name Title Board Seat Contact Info
Christina Lopes Ph.D Co-Founder & Chief Executive Officer
Benjamin Lewis Co-Founder & Chief Strategy Officer
Jonathan Lustgarten Ph.D Chief Technology Officer
Monica Lopes Chief Marketing Officer
Pedro Carrasco Chief of Staff
You’re viewing 5 of 11 executive team members. Get the full list »

FidoCure Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

FidoCure Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Borealis Ventures Venture Capital Minority 000 0000 000000 0
Polaris Partners Venture Capital Minority 000 0000 000000 0
Andreessen Horowitz Venture Capital Minority 000 0000 000000 0
CLF Partners Venture Capital Minority 000 0000 000000 0
Lerer Hippeau Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 13 investors. Get the full list »